Intravenous thrombolysis for acute ischemic stroke in Greece: the Safe Implementation of Thrombolysis in Stroke registry 15-year experience

医学 溶栓 四分位间距 改良兰金量表 冲程(发动机) 人口统计学的 内科学 急诊医学 物理疗法 缺血性中风 人口学 缺血 心肌梗塞 机械工程 社会学 工程类
作者
Georgios Tsivgoulis,Odysseas Kargiotis,Jobst Rudolf,Apostolos Komnos,Antonios Tavernarakis,Theodoros Karapanayiotides,John Ellul,Aristeidis H. Katsanos,Sotirios Giannopoulos,Maria Gryllia,Apostolos Safouris,Panagiotis Papamichalis,Κonstantinos Vadikolias,Panayiotis Mitsias,Georgios M. Hadjigeorgiou
出处
期刊:Therapeutic Advances in Neurological Disorders [SAGE Publishing]
卷期号:11: 175628641878357-175628641878357 被引量:10
标识
DOI:10.1177/1756286418783578
摘要

Intravenous thrombolysis (IVT) remains the only approved systemic reperfusion treatment for acute ischemic stroke (AIS), however there are scarce data regarding outcomes and complications of IVT in Greece. We evaluated safety and efficacy outcomes of IVT for AIS in Greece using the Safe Implementation of Thrombolysis in Stroke: International Stroke Thrombolysis Register (SITS-ISTR) dataset.All AIS patients treated with IVT in Greece between December 2002 and July 2017 and recorded in the SITS-ISTR were evaluated. Demographics, risk factors, baseline stroke severity [defined using National Institutes of Health Stroke Scale (NIHSS)], and onset-to-treatment time (OTT) were recorded. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and 3-month mortality rates. The efficacy outcomes evaluated a reduction in baseline NIHSS score at 2 and 24 h following IVT onset, 3-month favorable functional outcome [FFO; modified Rankin scale (mRS) scores of 0-1] and 3-month functional independence (FI; mRS-scores of 0-2). The safety and efficacy outcomes were assessed comparatively with previously published data from SITS national and international registries.A total of 523 AIS patients were treated with IVT in 12 Greek centers participating in the SITS-ISTR during the study period (mean age 62.4 ± 12.7; 34.6% women; median baseline NIHSS score: 11 points; median OTT: 150 min). The rates of sICH were 1.4%, 2.3%, and 3.8% according to the SIST-MOST, ECASS II, and NINDS criteria respectively. The median reduction in NIHSS score at 2 and 24 h was 3 [interquartile range (IQR): 1-5] and 5 (IQR: 2-8) points respectively. The 3-month FI, FFO and mortality were 66.5%, 55.6% and 7.9%. All safety and efficacy outcomes were comparable with available data from SITS-ISTR in other European countries.Our study underscores the safety and efficacy of IVT for AIS in Greece. Additional action is necessary in order to increase the availability of IVT in the Greek population and to include more centers in the SITS-ISTR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
1秒前
受伤凌蝶完成签到,获得积分10
2秒前
wenjiejiang完成签到,获得积分10
3秒前
3秒前
zly完成签到 ,获得积分10
4秒前
4秒前
李某人完成签到,获得积分10
4秒前
5秒前
小鱼完成签到,获得积分10
6秒前
小崽总完成签到,获得积分10
6秒前
挽风完成签到,获得积分10
9秒前
9秒前
dxs发布了新的文献求助10
9秒前
苹果沛柔完成签到,获得积分10
10秒前
111完成签到 ,获得积分10
10秒前
Amon完成签到 ,获得积分10
11秒前
结实寄柔完成签到,获得积分10
12秒前
dh完成签到,获得积分0
12秒前
超帅鸭子发布了新的文献求助10
13秒前
苹果沛柔发布了新的文献求助10
14秒前
16秒前
sure完成签到 ,获得积分10
18秒前
伶俐的不尤完成签到,获得积分10
18秒前
可乐完成签到,获得积分10
19秒前
乐乐乐乐乐乐应助scinature采纳,获得10
21秒前
angrymax完成签到,获得积分10
22秒前
俭朴的天薇完成签到,获得积分10
23秒前
Tanhm完成签到,获得积分10
25秒前
leolin完成签到,获得积分10
25秒前
25秒前
Dr-Luo完成签到 ,获得积分10
25秒前
26秒前
甜蜜的曼冬完成签到 ,获得积分10
27秒前
英姑应助宋老师采纳,获得30
27秒前
桐桐应助完美梨愁采纳,获得10
28秒前
Mm林完成签到,获得积分10
29秒前
我就是我完成签到,获得积分10
29秒前
盈滢完成签到 ,获得积分10
29秒前
Jay_Gavin应助白白采纳,获得10
30秒前
zy发布了新的文献求助10
31秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038388
求助须知:如何正确求助?哪些是违规求助? 3576106
关于积分的说明 11374447
捐赠科研通 3305798
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029